Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 11, 2026.
Active, not recruitingNCT06162715
Severe Obesity · Obesity · BMI Greater Than 30
Phase 2 / Phase 325 years - 65 yearsNashville, Tennessee, United States The goal of this pilot clinical trial is to determine the effectiveness of Tirzepatide in patients with persistent obesity (BMI \> 30) 12 months after bariatric surgery (Roux-en-Y Gastric Bypass). The investigators also aim to determine the freque…
RecruitingNCT07927816
Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia · In Vivo CAR-T · B-Cell Acute Lymphoblastic Leukemia
Phase 114 years - 75 yearsBeijing, Beijing Municipality, China This is a single-center, open-label, single-arm, prospective, investigator-initiated dose-escalation study to evaluate the safety, tolerability, preliminary efficacy, and cellular kinetics of an in vivo CAR-T cell immunotherapy targeting CD19 sequent…
RecruitingNCT07338292
Urologic Diseases · Prostate Biopsy · Flexible Cystoscopy · Circumcision · Stress · Anxiety · Pain
Not applicable18 years - 99 yearsPadova, Italy Though the efficacy of VRH is documented in various outpatient urological procedures and has provided promising preliminary information in prostate biopsy, its systematic use in urology remains poorly studied. Considering the potential of invasive ur…
Active, not recruitingNCT05551052
Colorectal Cancer · Adenomas Colon · Colon Cancer · Rectal Cancer · Colon Neoplasm · Colon Lesion · Colon Disease · Colon Polyp · Polyps · Adenoma · Rectal Diseases · Rectal Polyp · Gastrointestinal Neoplasms · Intestinal Neoplasms · Colonic Diseases, Functional · Intestinal Disease
Observational45 years - Not specifiedChula Vista, California, United States +1 The CRC DRAW study will assess the sensitivity and specificity of the blood-based, Next-Gen CRC Screening Test for the detection of CRC.
RecruitingNCT07688148
Solid Tumor Cancers
Phase 1 / Phase 218 years - Not specifiedBrussels, Belgium +3 The purpose of this clinical trial is to investigate the treatment for adult patients suffering from advanced or metastatic solid tumours and has 2 parts to the study: the Phase 1 where ascending doses of the experimental study drug, TAX2, will be te…
By invitationNCT04984447
Environmental Enteric Dysfunction
Not applicable18 years - 60 yearsBoston, Massachusetts, United States The investigators are seeking healthy adult participants 18-60 years and healthy pregnant women in their 2nd trimester of pregnancy for a research study to assess a new imaging device. The Tearney Laboratory at the Wellman Center for Photomedicine at…
RecruitingNCT07735533
Lymphoma, B Cell · Lymphoma Non-Hodgkin · High Grade B Cell Lymphoma · Richter Transformation Lymphoma · Grade 3b Follicular Lymphoma · Primary Mediastinal B Cell Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL)
Phase 1 / Phase 218 years - Not specifiedIrvine, California, United States +1 This study is a Phase 1/2 dose-finding and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV400. The study will enroll patients with relapsed/refractory B-cell malignancies, including large B-cell lymphoma (LBCL).
RecruitingNCT04571658
Nephrotic Syndrome in Children · Focal Segmental Glomerulosclerosis · Minimal Change Disease · Minimal Change Nephrotic Syndrome · Membranous Nephropathy · FSGS · MCD · MCD - Minimal Change Disease · Alport Syndrome
Not applicable1 years - 80 yearsAtlanta, Georgia, United States +13 NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
RecruitingNCT07190248
Non-small Cell Lung Cancer
Phase 318 years - Not specifiedBirmingham, Alabama, United States +189 Researchers want to learn if the study medicines calderasib and subcutaneous (SC) pembrolizumab can be used to treat non-small cell lung cancer (NSCLC) when given together. Calderasib is a targeted therapy for the KRAS G12C mutation. The goal of this…
CompletedNCT03479268
B-Cell Prolymphocytic Leukemia · Recurrent Chronic Lymphocytic Leukemia · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Follicular Lymphoma · Recurrent Lymphoplasmacytic Lymphoma · Recurrent Mantle Cell Lymphoma · Recurrent Marginal Zone Lymphoma · Recurrent Non-Hodgkin Lymphoma · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia · Refractory Diffuse Large B-Cell Lymphoma · Refractory Follicular Lymphoma · Refractory Lymphoplasmacytic Lymphoma · Refractory Mantle Cell Lymphoma · Refractory Marginal Zone Lymphoma · Refractory Non-Hodgkin Lymphoma · Refractory Small Lymphocytic Lymphoma · Richter Syndrome
Phase 118 years - Not specifiedDuarte, California, United States +1 This phase I trial studies the side effects and best dose of pevonedistat when given together with ibrutinib in participants with chronic lymphocytic leukemia or non-Hodgkin lymphoma that has come back or has stopped responding to other treatments. P…
CompletedNCT06999928
Hiv · Transmission Vertical · Viremia · Adherence, Treatment · Stigmatization · Socioeconomic Adversity · Health Care Utilization · Health Care Acceptability · Peer Group · Mothers
Not applicable18 years - Not specifiedBurnt Forest, Uasin Gishu County, Kenya Mentor Mothers (MMs) are peer supporters who help pregnant and postpartum women living with HIV (WLHIV) as they receive prevention of mother-to-child transmission of HIV (PMTCT) services in resource-limited settings like Kenya. Differentiated service…
RecruitingNCT07885098
Cardiovascular Physiology
Not applicable40 years - 75 yearsWroclaw, Poland This study will evaluate the effects of four weeks of oral supplementation with a double-standardized tart cherry (Prunus cerasus) and aronia (Aronia melanocarpa) extract on cardiovascular regulation and exercise performance in healthy endurance-trai…
Retrieved from ClinicalTrials.gov: Nov 11, 2026. Overall study status may differ from a particular location’s status.
